Researchers found that low grade irAEs after anti-PD-1 therapy were more common than previously reported and frequently persist after prolonged follow-up.
Prospective cohort study investigated the efficiency of a program that incorporates total-body photography and sequential digital dermoscopy imaging to monitor patients with primary melanoma.
A team of investigators created the myeloid index score, which captures the prognostic value of blood myeloid cells and may be used in the management of patients with melanoma.
A randomized study determined whether a follow-up phone call after Mohs surgery improved patient satisfaction, and the optimal timing for the call.
A team of international researchers sought to confirm a “dual pathway hypothesis” for the development of melanoma.
Using readily available clinicopathologic information, a team of investigators developed a risk calculator to predict disease recurrence in patients with thin melanomas.
Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i.
Histology slides, clinical data used to predict immune checkpoint inhibitor response in advanced melanoma.
Despite relying on glycolysis, there is growing evidence that many tumor types still have high levels of mitochondrial energy metabolism and functioning oxidative phosphorylation. One such subset of tumors is melanoma, potentially playing a role in both tumor progression and resistance to therapy. This has led researchers to wonder whether targeting mitochondrial respiration could be…
